ISSN: 2327-4972
+44-77-2385-9429
Chakra P Chaulagain
Department of Medicine, Division of Hematology and Oncology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA
Preclinical studies of anti-plasma cell monoclonal antibodies (elotuzumab and daratumumab) in patients with clonal plasma cell diseases such as multiple myeloma, AL amyloidosis, POEMS etc